CH

Ulrich Gluck

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrich Gluck. Retrieved from https://idiyas.com/inventor/ulrich-gluck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Ulrich Gluck: Innovator in Pharmaceutical Delivery Systems

Introduction

Ulrich Gluck is a notable inventor based in Switzerland, recognized for his contributions to the field of pharmaceuticals. His work focuses on improving the delivery mechanisms of pharmaceutical substances, particularly through nasal administration.

Latest Patents

Ulrich Gluck holds a patent for a "Pharmaceutically Active Composition And Dispensing Device." This invention relates to an improved pharmaceutical substance and an enhanced application device that facilitates more effective nasal administration of the substance. Despite his innovative work, he currently has 0 patents registered.

Career Highlights

Ulrich Gluck is associated with the Schweiz Serum & Impfinstitut Bern, where he applies his expertise in pharmaceutical development. His role at this institution allows him to contribute significantly to advancements in medical technology and patient care.

Collaborations

Throughout his career, Ulrich has collaborated with notable colleagues, including Reinhard Gluck and Andre Collioud. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ulrich Gluck's work in pharmaceutical delivery systems exemplifies the importance of innovation in healthcare. His contributions aim to enhance the effectiveness of drug administration, ultimately benefiting patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…